Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Related Posts
Amazon hit by strengthening dollar, underscoring risks in tech to overseas reliance
In its earnings report on Thursday, Amazon said the strong dollar is weighing on revenue, signaling the company is particularly exposed to currency swings.
Tesla plunges 36% in first quarter, worst performance for any period since 2022
Tesla had its third-worst quarter ever in the first three months of the year, a stretch that’s corresponded with Elon Musk’s time with the Trump […]
McDonald’s Shamrock Shake returns — and so does Grimace’s uncle
McDonald’s is bringing back the mascot Uncle O’Grimacey, Grimace’s uncle, to promote the seasonal milkshake.